This suggests that, in addition to their effect on SNAI2 and CDH gene expression, both DLK1 and DLK2 may affect other shared mechanisms that modulate the invasive properties of MDA-MB-231 and other cancer cells. The gene discussed is DLK2; the disease is cancer.